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Robert J. Boyle, MBChB, PhDa London, Farnborough, and Manchester, United Kingdom, and Sydney, AustraliaBackground: The incidence of anaphylaxis might be increasing.
Data for fatal anaphylaxis are limited because of the rarity of
this outcome.
Objective: We sought to document trends in anaphylaxis
admissions and fatalities by age, sex, and cause in England and
Wales over a 20-year period.
Methods: We extracted data from national databases that
record hospital admissions and fatalities caused by anaphylaxis
in England and Wales (1992-2012) and crosschecked fatalities
against a prospective fatal anaphylaxis registry. We examined
time trends and age distribution for fatal anaphylaxis caused by
food, drugs, and insect stings.
Results: Hospital admissions from all-cause anaphylaxis
increased by 615% over the time period studied, but annual
fatality rates remained stable at 0.047 cases (95% CI,
0.042-0.052 cases) per 100,000 population. Admission and
fatality rates for drug- and insect sting–induced anaphylaxis
were highest in the group aged 60 years and older. In contrast,
admissions because of food-triggered anaphylaxis were most
common in young people, with a marked peak in the incidence
of fatal food reactions during the second and third decades of
life. These findings are not explained by age-related differences
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956Conclusions: Hospitalizations for anaphylaxis increased
between 1992 and 2012, but the incidence of fatal anaphylaxis
did not. This might be due to increasing awareness of the
diagnosis, shifting patterns of behavior in patients and health
care providers, or both. The age distribution of fatal
anaphylaxis varies significantly according to the nature of the
eliciting agent, which suggests a specific vulnerability to severe
outcomes from food-induced allergic reactions in the second and
third decades. (J Allergy Clin Immunol 2015;135:956-63.)
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Acute, life-threatening systemic allergic reactions (anaphy-
laxis) can lead to cardiorespiratory arrest within minutes.1
For those affected, the threat of further episodes can lead to signif-
icant lifestyle restrictions and psychological consequences.2,3
Recent Australian data suggest that episodes of anaphylaxis,
particularly those triggered by drugs or food, might be
increasing.4 Recent US data suggest that at least 1.6% of the
population have a history of anaphylaxis,5 although this might
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immediate outcomes, such as fatality or admission to an intensive
care unit, are rare.6-8 Indeed, a recent report from a European
anaphylaxis registry relating to severe anaphylaxis found that
only 2% of more than 3000 cases of significant anaphylaxis
involved cardiorespiratory arrest.9
For this reason, there is a paucity of data relating to trends in
fatal (or near-fatal) allergic reactions over time. The apparent
increase in hospitalization caused by anaphylaxis might be due to
a real increase in disease or a change in health care provider or
patient behavior, such as improved management. A parallel
increase in fatal anaphylaxis incidence would provide supportive
evidence for the former. Therefore we assessed trends in hospital
admissions and fatalities caused by anaphylaxis in a population-
based data set that includes the largest reported series of cases of
fatal anaphylaxis. We explored time trends in all-cause and
specific-cause anaphylaxis events in different age groups and by
sex to understand which patients are at highest risk for severe
allergic reactions. Previous small case series suggest that
teenagers and young adults might be at the highest risk of fatal
food-induced anaphylaxis for unknown reasons,10 but this has not
been confirmed in large population-based data sets and might be
confounded by age-related differences in the incidence of
anaphylaxis.METHODS
We examined time trends and age/sex distribution for hospital admissions
and fatalities caused by anaphylaxis in England and Wales over a 21-year
period (1992-2012). We further analyzed the data for differences in time trend
and age distribution by triggering agent (food, iatrogenic causes [eg, oral and
parenteral medication and contrast media], and insect stings).Anaphylaxis admission data
Hospital admission data for England andWales are collated by the Hospital
Episodes Statistics database (coordinated through the Health & Social Care
Information Centre) and the Patient Episode Database for Wales (National
Health Service Wales Informatics Service), respectively. We extracted data
relating to hospitalizations in which anaphylaxis was the primary diagnosis for
the calendar years 1992 to 2012. We did not include emergency department
visit that did not result in a hospital admission. For analysis of trigger-specific
age distribution, we limited data extraction to the years 1998 to 2012 to avoid
confounding because of International Classification of Diseases (ICD) coding
changes from ICD-9 to ICD-10 that took place before 1998. Admissions
before 1998 were identified by using ICD-9 codes 995.0 (anaphylaxis,
unspecified) and 995.6 (food-induced anaphylaxis). All hospital admissions
from 1998 onward were included where the principal diagnosis corresponded
to the following ICD-10 (international version) codes: anaphylactic shock due
to adverse food reactions (T78.0); anaphylactic shock, unspecified (T78.2);
and anaphylactic shock due to adverse effects of correct drug or medicament
properly administered (T88.6). Hospitalizations in which a primary T78 code
was associated with a secondary X23 code were classified as being caused by
insect sting–related anaphylaxis. We also analyzed the data to assess the
possible effect of the introduction of a maximum 4-hour wait in emergency
departments by the United Kingdom (UK) Government in 2004.Fatal anaphylaxis data
All deaths in England and Wales are recorded by a medical doctor, and
these data are collected by the Office for National Statistics (ONS). Since
1992, we (R.P. and M.H.G.) have collected data on all cases in which
anaphylaxis was included as a cause of death. Cases were entered into a
registry within the parameters permitted by the local research ethics
committee and approved by the ONS. Additional notifications were collected
from patient representative organizations, coroners, the police service,
pathologists, and media reports, as previously described.1
Verification of fatal anaphylaxis data
The attribution and coding of deaths can be unreliable, and therefore caution
is neededwhen interpreting fatal anaphylaxis statistics. It is important that both
the probability that a death was due to anaphylaxis and that the trigger for the
reaction was correctly determined are taken into account when analyzing the
data. Since the inception of the registry in 1992, we (R.P. and M.H.G.) have
attempted to investigate the circumstances of every fatal anaphylactic episode
using a previously outlinedmethodology.1 In brief, for each death, the probabil-
ity that it was caused by anaphylaxis and the probability that the cause had been
correctly identified were assessed. Deaths caused by an acute asthma exacerba-
tion were included only where there was strong evidence that the episode was
triggered by an identified allergen to which the deceased patient had a known
allergy. Deaths caused by asphyxia from upper airways angioedema in patients
with hereditary angioedema or in those taking angiotensin-converting enzyme
inhibitors were excluded when an allergic cause for the reaction seemed
improbable. We also excluded cases of amniotic fluid emboli (anaphylactoid
syndrome of pregnancy). Because of difficulties in obtaining sufficient data to
confirm the precise trigger for some cases of fatal anaphylaxis, particularly
those caused by medication, we have included cases from the ONS database
in which sufficient information was available to determine that anaphylaxis
was the likely cause of death but not to confirm the specific cause (eg, medica-
tion) with high probability. We classified these as unconfirmed cases.Prescription of epinephrine autoinjector devices
We extracted data from the National Health Service Business Services
Authority Prescription Cost Analysis databases from 1998 to 2012, which record
all prescriptions issued by health practitioners through the English public health
system.Wegrouped epinephrine autoinjector devices into 150- and 300-mg doses,
irrespective of device. We were unable to obtain similar data for Wales.Statistics
Age-standardized rates (ASRs) for death and hospital admissions were
calculated by standardizing to the age distribution of the population in
mid-2001 (for 1992-2012) and mid-2006 (1998-2012), as reported by the
ONS; thus cases (admissions or fatalities) are expressed per 100,000
population. Poisson regression was used to estimate the rate ratio for the
annual increase in rates by calendar year, as previously described.11 Results
are presented as rate ratios and 95%CIs. A rate ratio of 1.0 indicates no annual
change in rate, and a 95% CI that includes 1.0 indicates the observed rate ratio
is not statistically significant.RESULTS
Hospital admissions because of all-cause anaphylaxis
increased steadily from 1992 for both sexes but appear to have
reached a plateau since 2008 (Fig 1, A). Over the study period,
there was an increase in hospital admissions of 615%, from
1.0 to 7.0 cases per 100,000 population per annum. The estimated
rate ratio (multiplicative increase of the rate per year over the
study period) was 1.073 (95% CI, 1.071-1.075; P < .001). This
trend was not clearly related to either a change in ICD coding
(ICD-9 to ICD-10) or the introduction of a 4-hour maximum
observation in emergency departments in the UK (Fig 1, A),
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FIG 1. Time trends in hospital admissions (A) and fatalities (B) for all-cause
anaphylaxis between 1992 and 2012. Vertical bars represent SEMs. FIG 2. Age distribution of ASRs for admissions (1998-2012; A) and fatalities
(1992-2012; B) caused by anaphylaxis by triggering agent (food, iatrogenic
causes, and insect stings).
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In contrast, fatality rates from all-cause anaphylaxis remained
stable at a mean of 0.047 cases (95% CI, 0.042-0.052 cases) per
100,000 population per annum (Fig 1, B), with no increase in
fatalities during this period (estimated rate ratio, 1.00; 95% CI,
0.98-1.01; P > .05). There was no difference in the distribution
of fatal cases by sex (P > .05).Food-induced anaphylaxis: Admissions and
fatalities
There were a total of 14,675 hospital admissions coded as
anaphylaxis because of a food trigger between 1998 and 2012,
with the highest rate in children and adults less than 24 years old
(Fig 2, A). Hospital admissions increased significantly between
1998 and 2012, from an ASR of 1.2 to 2.4 per 100,000 population
per annum, resulting in an increase of 106% (P <.0001; Fig 3, A).
The estimated rate ratio was 1.05 (95% CI, 1.05-1.06) over the
study period. The estimated increases in ASR for the age groups
of 0 to 14 years, 15 to 59 years, and 60 or more years were 137%
(rate ratio, 1.05; 95% CI, 1.05-1.06; P < .001), 105% (rate ratio,
1.06; 95% CI, 1.06-1.07; P < .001), and 58% (rate ratio, 1.04;
95% CI, 1.03-1.05; P < .001), respectively. There was no
significant difference in the ASR by sex (P > .05; see Fig E1, A,
in this article’s Online Repository at www.jacionline.org). Male
subjects outnumbered female subjects (1.7:1) among children
less than 15 years of age, whereas female subjects outnumberedmale subjects (1.4:1) among those older than 15 years (see
Fig E1, A).
One hundred twenty-four fatalities were assessed as being
highly likely to be caused by ingestion of a food allergen between
1992 and 2012. The mean age of fatal food-induced cases of
anaphylaxis was 25 years (95% CI, 22-28 years). The ASR for
fatal food-induced anaphylaxis was 0.011 cases (95% CI,
0.009-0.013 cases) per 100,000 population per annum, with a
peak in the 10- to 29-year age groups (Fig 2, B). This rate
remained stable over the study period (estimated rate ratio,
0.99; 95% CI, 0.96-1.02; P > .05; Fig 3, B). We did not observe
a significant difference in the age distribution of fatal cases by
sex (P > .05, see Fig E1).
The triggering food was recorded as identified in 95 (77%) of
124 cases (Fig 4,A andB). Of these, 69 (73%) of 95 fatalities were
caused by allergy to peanut or tree nuts. Cow’s milk accounted for
8 (21%) of 39 fatalities in children less than 16 years of age (Fig 4,
A). Ninety-seven (78%) of 124 fatal cases were in patients with a
physician’s diagnosis of asthma, 86 (69%) were known to have a
food allergy before the fatal event, and at least 26 (21%) had
experienced prior anaphylaxis. Thirty-three (27%) fatalities
were triggered by allergen ingestion in the patient’s own home,
whereas 25 (20%) occurred in restaurants. Among school-age
children (age, 4-18 years), 8 (17%) of 48 fatalities occurredwithin
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FIG 3. Time trend in ASRs for admissions to hospital with anaphylaxis (A, C, and E) and fatalities (B, D, and
F) by trigger: food, iatrogenic causes, and insect stings. Vertical bars represent SEMs.
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identified in 100 cases: 27 (27%) were caused by the consumption
of the allergen in prepackaged foods. Fifty-nine (59%) reactions
were to food products provided by a catering establishment, of
which one quarter were purchased from takeaway outlets.Anaphylaxis of iatrogenic causes: Admissions and
fatalities
A total of 8161 admissions to the hospital were coded as
iatrogenic cause–related anaphylaxis between 1998 and 2012,
with the highest admission rates seen from the seventh decade
onward (Fig 2, A). Admissions to the hospital increased
significantly from an ASR of 0.78 to 1.4 per 100,000 population
per annum, an increase of 82% (Fig 3,C). The estimated rate ratio
was 1.04 (95% CI, 1.04-1.05; P < .001) over the study period.
The mean ASR in the 0- to 14-year age group was stable
throughout the study period at 0.17 (95% CI, 0.16-0.20)
admissions per 100,000 population per annum (no significant
increase, P > .05). This is in contrast to the age groups of 15 to
59 years and 60 years and older: the estimated increase in ASR
for those 15 to 59 years and those 60 or more years of age were
71% (rate ratio, 1.04; 95% CI, 1.03-1.04; P < .001) and 85%
(rate ratio, 1.05; 95% CI, 1.04-1.05; P < .001), respectively.Two hundred sixty-three fatalities were recorded as iatrogenic
cause–related anaphylaxis between 1992 and 2012. The mean age
of fatal cases of anaphylaxis of iatrogenic causes was 58 years
(95% CI, 56-61 years), with fatalities rare before the fourth
decade of life. The overall ASR of fatal drug-induced anaphylaxis
was 0.024 (95% CI, 0.021-0.026) per 100,000 population per
annum, peaking in the seventh decade of life onward (Fig 2, B).
This rate remained stable over the study period (estimated rate
ratio, 1.01; 95% CI, 0.99-1.03; P > .05; Fig 3, D).Insect sting–induced anaphylaxis: Admissions and
fatalities
Between 1998 and 2012, there were 2688 admissions to the
hospital because of anaphylaxis caused by insect stings (Fig 2, A).
Admissions were rare in the first 3 decades of life. There was a
significant increase in admissions during the study period,
from an ASR of 0.1 to 0.5 per 100,000 population per annum
(P < .001; Fig 3, E). The estimated rate ratio was 1.12 (95% CI,
1.10-1.13), which is equivalent to an increase of 410% over the
study period. This increase was due to an increase in ASR in
the 15- to 59-year and 60-year and older age groups, both of
which saw an increase in admissions with an estimated rate
ratio of 1.11 (95% CI, 1.09-1.12; P < .001) and 1.17 (95% CI,
FIG 4. Cause of fatal food-induced anaphylaxis cases by trigger in children (A) and adults (B) and by 5-year
groups (C).
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age group remained stable during this time (estimated rate ratio,
0.99; 95% CI, 0.95-1.04; P > .05).
We identified 93 deaths caused by sting-induced anaphylaxis
between 1992 and 2012. The mean age of fatal cases was 59 years
(95% CI, 56-63 years), with fatalities rare before the fifth
decade of life. The mean ASR for fatal insect sting–induced
anaphylaxis was 0.009 (95% CI, 0.007-0.010) per 100,000
population per annum (Fig 2, B). This rate remained stable over
the study period (estimated rate ratio, 0.98; 95% CI, 0.94-1.01;
P > .05; Fig 3, F).Differences in age distribution of fatal anaphylaxis
by trigger
Fatalities were most common in older persons for drug- and
insect sting–induced anaphylaxis, whereas for food-triggered
reactions, fatalities peaked in the second and third decades
(P < .01, Mann-Whitney test).
To assess whether the different age distribution of fatal
food-induced anaphylaxis might be explained by age-related
differences in the prevalence of food-induced anaphylaxis, we
attempted to normalize the fatality data by expressing them as a
proportion of all hospital admissions for that age group (as a
surrogate measure for the incidence of severe allergic reactions),
as shown in Fig 5. In contrast to fatal outcomes from drug- and
insect sting–induced anaphylaxis, which increased with age, fatal
outcomes from food-induced anaphylaxis were most common in
the second decade of life and very rare in adults older than
60 years.Provision of epinephrine autoinjector devices
The prescription of epinephrine autoinjector devices to
residents in England increased by 325% from 1998 to 2012
(P < .0001, Fig 6). The estimated rate ratio was 1.113 (95% CI,
1.112-1.113) over the study period.DISCUSSION
To our knowledge, this is the largest data set of fatal
anaphylaxis cases reported, which allows more robust conclu-
sions regarding trends in fatal anaphylaxis to be made compared
with previous studies. Hospital admissions for anaphylaxis in
England and Wales increased 7-fold from 1992 to 2012, although
the incidence might have reached a plateau over the last 5 years.
We found no evidence for an increase in fatal anaphylaxis over the
same period, suggesting that changes in the recognition and
management of anaphylaxis might explain some of the observed
increase in anaphylaxis-related hospitalizations. These findings
are similar to those reported for the United States from an analysis
of health databases (which might be subject to inclusion bias)
over a shorter period of time.12 However, we also analyzed trends
in anaphylaxis admissions and fatalities by cause in a national
population over 2 decades: we found that the age distribution of
anaphylaxis resulting in hospital admission and fatal anaphylaxis
varies significantly according to trigger.
Of note, the ASRs for hospital admissions caused by
anaphylaxis in our study are consistent with those previously
reported for Australia,13 New York State,14 and the United
States.12 Although there has been an increase in all-cause hospital
admissions over the past decade in England,15 the increase in
FIG 5. Incidence of fatal anaphylaxis expressed as a proportion of hospital
admissions caused by anaphylaxis by trigger.
FIG 6. Prescription of epinephrine autoinjectors to English residents from
1998 to 2012.
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for all-cause admissions. Therefore we consider that the increase
observed is not accounted for by the general trend in increasing
emergency admissions discussed elsewhere.15
Our finding that hospitalizations for anaphylaxis have
increased steadily while fatality rates have remained stable has
several possible explanations. Improved recognition/coding/
awareness of anaphylaxis might have led to an increase in patient
attendance/hospital admission/diagnostic coding without a realincrease in disease incidence. The rate of anaphylaxis might have
increased (mirroring the increase in prevalence of atopy reported
elsewhere16), but the management of severe allergic reactions has
improved at the same time, resulting in a reduced case fatality
rate. In support of this, we show that prescriptions for epinephrine
autoinjectors have increased over the same time period. However,
arguing against a protective role for epinephrine autoinjectors is
our previous observation that up to one third of fatal
food-induced anaphylactic episodes in the UK occur despite
prompt administration of intramuscular epinephrine17 and our
current finding of increased admissions without any increase in
fatalities for anaphylaxis due to iatrogenic causes (a situation in
which epinephrine autoinjectors are not commonly prescribed).
It is possible that other aspects of anaphylaxis management
have improved sufficiently such that no increase in the case fatal-
ity rate was observed. A final possibility is that although anaphy-
laxis has increased in incidence, this increase is of a type of
anaphylaxis that does not result in fatalities; however, we consider
this to be unlikely.
Diagnosis of anaphylaxis might be more difficult in very young
children and more prone to misclassification, and therefore it is
possible that the peak in the rate of hospitalization for
food-induced anaphylaxis in early childhood is partly artifactual
(particularly in view of the low rate of fatalities in younger
children). In 2011, new national guidelines were released that
recommended 6 to 12 hours of observation after an anaphylactic
episode and hospital admission for children less than 16 years of
age (but not adults) with anaphylaxis18; however, the majority of
the data presented here precede this advice. Food allergy is most
prevalent in infants and young children, and preschool children
with food allergy are known to have a high frequency of allergic
reactions19; therefore it is likely that food-induced allergic
reactions in general are most common in preschool children.
The age- and sex-specific distribution of hospital admissions for
food-induced anaphylaxis in England and Wales is very similar
to what has been previously reported in Australia.13 The
increasing trend for antibiotic prescriptions in the UK, with the
highest rates of antibiotic prescribing occurring in older age
groups,20 might explain (at least in part) both the increase in
anaphylaxis of iatrogenic cause over time and the age distribution
observed.
Fatalities and admissions were most common in those 60 years
of age and older for iatrogenic cause– and insect sting–induced
anaphylaxis, which is in contrast to food-induced anaphylaxis, for
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decades. These observations might be confounded by age-related
differences in the incidence of food-induced allergic reactions;
that is, a lower incidence of fatal, food-triggered reactions in older
adults might reflect a lower incidence of food-induced
anaphylaxis in this age group. We attempted to account for this
by normalizing the data as a proportion of hospital admissions.
We found that the age-related differences in fatal anaphylaxis by
causative trigger are not explained by differences in the rate of
less severe allergic reactions, a finding we have also noted for
anaphylaxis in Australia.21
It has been proposed that the increased risk of food-induced
anaphylaxis-related fatalities in teens and younger adults might
be due to risk-taking behaviors.22,23 However, such factors are
less likely to be relevant to adults in the fourth decade of life,
an age group we have shown is still associated with a high risk,
although cofactors (eg, exercise or alcohol consumption) might
affect this age group more than others. Therefore our data raise
the possibility that food-induced anaphylaxis might not have
the same physiologic basis as anaphylaxis triggered by insect
stings or iatrogenic causes. It is noteworthy that symptoms of
anaphylaxis vary according to trigger in fatal,1 severe (with
hypoxemia and/or hypotension),24 and less severe25 reactions.
Cardiovascular compromise is common in patients with severe
reactions to drugs and insect venom1,9,24,25 but not those with
food-triggered reactions, in whom life-threatening manifestations
are generally caused by laryngopharyngeal and/or respiratory
compromise.1,9 Where cardiovascular arrest occurs in food-
triggered reactions, this is generally thought to be secondary to
respiratory arrest.1 In our series more than 75% of patients with
fatalities caused by food-triggered anaphylaxis had asthma. In a
large prospective study of severe anaphylaxis in an unselected
cohort presenting for emergency care in Australia, underlying
lung disease was predictive of severe respiratory involvement.24
Furthermore, many patients with food allergy without a formal
diagnosis of asthma have underlying bronchial hyperreactivity,26
which can predispose to more severe reactions.27 However, the
age distribution of fatal asthma is different to that seen here for
fatal food-induced anaphylaxis,28 suggesting that the vulnera-
bility of teenagers and younger adults to severe food-induced
anaphylaxis is not directly related to an age-related predisposition
to fatal bronchospasm. Our data suggest that there might be other
factors, potentially other age-related physiologic processes, that
account for the vulnerability of this age group to fatal outcomes
from food-induced allergic reactions. We did not find any
significant sex-related differences in the age distribution for fatal
food-induced anaphylaxis, suggesting that any influences are not
sex specific. Investigating the nature of these physiologic
influences through mechanistic assessments might lead to
important advances in our understanding of determinants of
severity in patients with food-induced allergic reactions.
We observed a clear increase in fatalities with age for
anaphylaxis of iatrogenic causes and that caused by insect stings.
This could be explained by a combination of age-related
increased prevalence of allergy to these triggers, as well as
increased susceptibility to anaphylaxis at older ages. Anaphylaxis
triggered by iatrogenic causes and insect stings are more likely to
result in cardiovascular involvement,1,9,24,25 perhaps because of
more rapid exposure of allergen (for parenteral medication and
venom) to the cardiovascular system. However, arguing against
this is the observation that food allergens are rapidly absorbedacross the oral mucosa, resulting in plasma levels sufficient to
trigger an effector cell response,29 and thus might be expected
to cause both cardiovascular and respiratory symptoms. Further-
more, severe allergic reactions to oral medication (eg, antibiotics)
are frequently associated with cardiovascular manifestations,24,25
which is more in common with anaphylaxis caused by parenter-
ally administered medication in terms of symptoms elicited.
The increased mortality in older age groups could represent an
age-related susceptibility to anaphylaxis-induced cardiovascular
effects, including, but not limited to, a possible role for cardiac
mast cells.30 Younger patients might be more able to compensate
for a cardiovascular insult during an anaphylactic reaction, thus
explaining the relative absence of cardiovascular symptoms in
patients with fatal food-induced anaphylaxis. However, this
cannot completely explain the differences in age-related
susceptibility to fatal outcome between different triggers of
anaphylaxis seen in our study.
The strength of this study is that we used a large population-
based data set, which allows for more detailed analysis of time
trends and age/sex distribution of anaphylaxis by cause. However,
our data do have some limitations. The cause of hospitalization
for anaphylaxis might be miscoded, with either the eliciting
trigger or even the diagnosis being incorrect. To limit this, we
used diagnoses assigned at discharge by the medical team after
the patient would have been reviewed by at least one senior
physician. Furthermore, we used a similar methodology
throughout the study period, and therefore our data are useful in
terms of monitoring time trends in hospital admissions caused by
anaphylaxis. We did not include cases of anaphylaxis seen in
emergency departments that did not require hospitalization
because these data sets are incomplete and very prone to
miscoding.31 Similarly, we could not include a population-
based assessment of the prevalence of anaphylaxis in consumers
who do not present to emergency services, something that is
common.23 With regard to fatalities, cases were registered on
an independent and dedicated registry and only included where
the balance of probabilities suggested anaphylaxis was the likely
cause. Because of a concern that some food-triggered deaths
might have been wrongly attributed to asthma in causality during
hospital certification,32 we (R.P. and M.H.G.) undertook a
separate study during 2003 and 2004, when all asthma deaths in
the UK up to the age of 32 years were studied prospectively for
a 12-month period to determine whether the fatal attack had
been triggered by food allergy. On the basis of this research and
others, it is unlikely that cases of fatal food-induced anaphylaxis
were miscoded as fatal asthma in this data set.17,28
In summary, our data show that the rate of hospitalization for
anaphylaxis has increased markedly in England and Wales over a
21-year period, yet the rate of fatal anaphylaxis remains stable.
We have also identified marked differences in the age distribution
of anaphylaxis admissions and fatalities according to trigger,
which might offer important clues to the underlying pathophys-
iology. Further investigation of age-related vulnerability to
anaphylaxis can enhance our understanding of factors that
predispose to poor outcomes in patients with severe allergic
reactions.
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d Hospitalizations for anaphylaxis increased between 1992
and 2012, but rates of fatal anaphylaxis did not.
d The age distributions of anaphylaxis resulting in hospital
admission and fatal anaphylaxis vary significantly accord-
ing to trigger.
d Fatal food-induced anaphylaxis is most common during
the second and third decades of life.REFERENCES
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FIG E1. Distribution of hospital admissions (A) and fatalities (B) caused by
food-induced anaphylaxis by age and sex.
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